611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO, CA
Market cap: $4.4B (2/10/2026)
Price: $75.98
Material Agreement with Genentech for GLP-1 Receptor Agonists
Structure Therapeutics Announces Follow-On Public Offering of ADSs
Topline ACCESS Phase 2b Results
Reports Third Quarter 2025 Financial Results and Recent Highlights
Earnings Release
Shareholder votes
Reports First Quarter 2025 Financial Results and Recent Highlights
Annual Report to Security Holders
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
S-1
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report